Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $2.09 billion. The enterprise value is $2.13 billion.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 356.51 million shares outstanding. The number of shares has increased by 17.64% in one year.
| Current Share Class | 356.51M |
| Shares Outstanding | 356.51M |
| Shares Change (YoY) | +17.64% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 11.88% |
| Owned by Institutions (%) | 37.61% |
| Float | 189.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 125.48 |
| PS Ratio | 66.12 |
| Forward PS | 13.58 |
| PB Ratio | 103.07 |
| P/TBV Ratio | 976.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 67.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.82, with a Debt / Equity ratio of 4.86.
| Current Ratio | 4.82 |
| Quick Ratio | 3.93 |
| Debt / Equity | 4.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.29 |
Financial Efficiency
Return on equity (ROE) is -1,145.42% and return on invested capital (ROIC) is -80.72%.
| Return on Equity (ROE) | -1,145.42% |
| Return on Assets (ROA) | -42.07% |
| Return on Invested Capital (ROIC) | -80.72% |
| Return on Capital Employed (ROCE) | -76.58% |
| Weighted Average Cost of Capital (WACC) | 9.87% |
| Revenue Per Employee | $197,469 |
| Profits Per Employee | -$2.40M |
| Employee Count | 160 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Precigen has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +312.68% in the last 52 weeks. The beta is 1.06, so Precigen's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +312.68% |
| 50-Day Moving Average | 4.31 |
| 200-Day Moving Average | 4.05 |
| Relative Strength Index (RSI) | 77.20 |
| Average Volume (20 Days) | 5,908,423 |
Short Selling Information
The latest short interest is 40.25 million, so 11.29% of the outstanding shares have been sold short.
| Short Interest | 40.25M |
| Short Previous Month | 39.87M |
| Short % of Shares Out | 11.29% |
| Short % of Float | 21.25% |
| Short Ratio (days to cover) | 10.57 |
Income Statement
In the last 12 months, Precigen had revenue of $31.60 million and -$383.42 million in losses. Loss per share was -$1.17.
| Revenue | 31.60M |
| Gross Profit | -11.18M |
| Operating Income | -90.00M |
| Pretax Income | -204.42M |
| Net Income | -383.42M |
| EBITDA | -86.33M |
| EBIT | -90.00M |
| Loss Per Share | -$1.17 |
Full Income Statement Balance Sheet
The company has $56.25 million in cash and $98.25 million in debt, giving a net cash position of -$42.00 million or -$0.12 per share.
| Cash & Cash Equivalents | 56.25M |
| Total Debt | 98.25M |
| Net Cash | -42.00M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | 20.24M |
| Book Value Per Share | 0.06 |
| Working Capital | 80.57M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$115.33 million and capital expenditures -$1.63 million, giving a free cash flow of -$116.96 million.
| Operating Cash Flow | -115.33M |
| Capital Expenditures | -1.63M |
| Depreciation & Amortization | 3.67M |
| Net Borrowing | 92.82M |
| Free Cash Flow | -116.96M |
| FCF Per Share | -$0.33 |
Full Cash Flow Statement Margins
| Gross Margin | -35.39% |
| Operating Margin | -284.85% |
| Pretax Margin | -646.99% |
| Profit Margin | n/a |
| EBITDA Margin | -273.24% |
| EBIT Margin | -284.85% |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.64% |
| Shareholder Yield | -17.64% |
| Earnings Yield | -18.35% |
| FCF Yield | -5.60% |
Analyst Forecast
The average price target for Precigen is $12.45, which is 112.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.45 |
| Price Target Difference | 112.46% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 256.17% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -19.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.91 |
| Piotroski F-Score | 4 |